These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 5030782

  • 1. [Blood levels of cephalosporin in patients with chronic kidney insufficiency and with or without hemodialysis].
    Lobuseva AN, Fomina IP, Vasiliev VK, Levitskiĭ ER, Sagalovich OM.
    Antibiotiki; 1972 Mar; 17(3):277-80. PubMed ID: 5030782
    [No Abstract] [Full Text] [Related]

  • 2. [Plasmatic half-life of a new cephalosporin in a patient with chronic renal insufficiency].
    Humbert G, Malandain H, Acar J, Fillastre JP.
    Nouv Presse Med; 1972 May 20; 1(21):1438. PubMed ID: 5036700
    [No Abstract] [Full Text] [Related]

  • 3. [Plasma half life of a new cephalosporin in uremic patients].
    Fillastre JP, Humbert G, Malandain H, Dubois D, Daufresne MF, Robert M.
    J Urol Nephrol (Paris); 1973 May 20; 79(4):384. PubMed ID: 4720136
    [No Abstract] [Full Text] [Related]

  • 4. [Serum levels of a new cephalosporin, cephacetrile, as a function of renal excretion capacity].
    Brogard JM, Ruscher H, Frankhauser J, Kuntzmann F, Lavillaureix J.
    Pathol Biol (Paris); 1973 Jun 20; 21(6):671-9. PubMed ID: 4581199
    [No Abstract] [Full Text] [Related]

  • 5. [Effect of hemodialysis on the cyclic nucleotide content of thrombocytes in patients with chronic kidney failure].
    Rud'ko IA, Kulakov GP, Kubatiev AA.
    Urol Nefrol (Mosk); 1987 Jun 20; (5):47-50. PubMed ID: 3424469
    [No Abstract] [Full Text] [Related]

  • 6. [Parenteral administration of a new cephalosporin in patients with chronic kidney failure. Study of plasmatic half-life of the antibiotic in relation to glomerular clearance].
    Malandain H, Humbert G, Fillastre JP, Acar J, Dubois D, Leroy J, Robert M, Daufresne MF.
    Pathol Biol (Paris); 1973 Mar 20; 21(3):233-9. PubMed ID: 4574486
    [No Abstract] [Full Text] [Related]

  • 7. [The effect of hemodialysis on the level of cytoplasmic Ca2+ in the thrombocytes of patients with chronic kidney failure].
    Rud'ko IA, Kubatiev AA, Tsalenchuk IaP.
    Urol Nefrol (Mosk); 1993 Mar 20; (4):37-9. PubMed ID: 8310566
    [Abstract] [Full Text] [Related]

  • 8. [Effect of renal insufficiency and hemodialysis on cephacetrile pharmacokinetics].
    Nissenson AR, Levin NW, Parker RH.
    Arzneimittelforschung; 1974 Sep 20; 24(9b):1470-3. PubMed ID: 4479806
    [No Abstract] [Full Text] [Related]

  • 9. The binding of chloramphenicol to serum proteins in patients with chronic renal insufficiency.
    Grafnetterová J, Vodrázka Z, Jandová D, Schück O, Tomásek R, Lachmanová J.
    Clin Nephrol; 1976 Oct 20; 6(4):448-50. PubMed ID: 975643
    [Abstract] [Full Text] [Related]

  • 10. Effect of renal failure and hemodialysis on cephacetrile pharmacokinetics.
    Nissenson AR, Levin NW, Parker RH.
    Clin Pharmacol Ther; 1972 Oct 20; 13(6):887-94. PubMed ID: 5081601
    [No Abstract] [Full Text] [Related]

  • 11. [The mechanisms of the development of arterial hypertension in patients with chronic kidney failure treated by hemodialysis].
    Konstantinov IuV, Komandenko MS, Nikolaeva AA, D'iachuk MM.
    Urol Nefrol (Mosk); 1993 Oct 20; (3):39-41. PubMed ID: 7941161
    [Abstract] [Full Text] [Related]

  • 12. [Behavior of Plasma Renin Activity (PRA) during hemodialysis treatment].
    Bucciante G, Da Tos A, Bernardi A, Cattano G, Pianca P, De Toni R.
    Minerva Med; 1974 Jun 16; 65(46):2549-55. PubMed ID: 4843596
    [No Abstract] [Full Text] [Related]

  • 13. [The nature of the humoral hemolytic factors in patients with chronic kidney failure].
    Ershova LI, Gorbunova NA.
    Ter Arkh; 1997 Jun 16; 69(7):46-50. PubMed ID: 9424758
    [Abstract] [Full Text] [Related]

  • 14. [Effect of recombinant human erythropoietin on the rate of Na+,H+-exchange in erythrocytes of patients with chronic kidney insufficiency treated by hemodialysis].
    Kubatiev AA, Rud'ko IA, Ermolenko VM.
    Biull Eksp Biol Med; 1997 Dec 16; 124(12):613-5. PubMed ID: 9483309
    [No Abstract] [Full Text] [Related]

  • 15. [Study of ampicillin absorption in patients with chronic kidney failure].
    Lobuseva AN, Vasina TA, Zeĭdlits LA, Levitskiĭ ER, Navashin SM.
    Antibiotiki; 1971 Dec 16; 16(4):350-4. PubMed ID: 4998598
    [No Abstract] [Full Text] [Related]

  • 16. What influences the level of oxidative stress as measured by 8-hydroxy-2'-deoxyguanosine in patients on hemodialysis?
    Mastalerz-Migas A, Steciwko A, Pokorski M, Pirogowicz I, Drobnik J, Bunio A, Muszyńska A, Jasińska A.
    J Physiol Pharmacol; 2006 Sep 16; 57 Suppl 4():199-205. PubMed ID: 17072047
    [Abstract] [Full Text] [Related]

  • 17. [Change in the activity of blood plasma renin in chronic renal insufficiency during treatment with hemodialysis].
    Barsegian BA.
    Ter Arkh; 1978 Sep 16; 50(7):127-9. PubMed ID: 715710
    [No Abstract] [Full Text] [Related]

  • 18. [Blood 17-hydroxycorticosteroids and their elimination during hemodialysis in acute and chronic renal insufficiency].
    Timokhov VS, Ryzhenko VM, Shaposhnikova VV.
    Ter Arkh; 1976 Sep 16; 48(10):99-104. PubMed ID: 1024286
    [No Abstract] [Full Text] [Related]

  • 19. Serum transcortin levels in patients with chronic hemodialysis.
    De Moor P, Faict D, Verberckmoes R.
    Ann Biol Clin (Paris); 1985 Sep 16; 43(3):267-9. PubMed ID: 3927790
    [Abstract] [Full Text] [Related]

  • 20. [The trace elements zinc and copper in chronic renal failure].
    Prehn B.
    Z Urol Nephrol; 1988 Jan 16; 81(1):35-42. PubMed ID: 3364046
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.